NEW WHITE PAPER: Solving Atypical Protein Expression with Transposase Technology Dive in today!

About Us
Our Services
News & Resources
- News & Blogs
- Resources
Careers

Search

Contact Us

Search

Contact Us

About Us
Our Services
News & Resources
- News & Blogs
- Resources
Careers

Our Company

About Us
Our History
Mission & Values
Executive Leadership

Locations

Global Facilities Network
Seattle
Copenhagen
Heidelberg
Milan
Chiba
Yokohama

Policies

Environment, Health & Safety
Group Privacy Policies

Offerings

Mammalian
Microbial
pDNA
Viral Vectors
Cell Therapy
mRNA

Services

Tech Transfer
Process Development
Cell Line Development
Analytical & Formulation Development
Process Validation
cGMP Manufacturing
Quality Systems & Inspection Management
Fill & Finish Services

Specialized Platforms & Programs

AGCellerate™ mAb & LVV Programs
ProntoLVV™ Lentiviral Vector Platform
BravoAAV™ Adeno-Associated Vector Platform
Proveo™ ADC Program
CMC Jumpstart™ Program

News & Blogs

Press Releases
Biopharma Thought Leadership Blog
Events & Conferences

Resources

Research & Scientific Content
Fact Sheets
Case Studies
Video Library
Media Kit

Fact Sheet Quick Links

Global cGMP Manufacturing (PDF)
CHEF1^TM Expression Technology (PDF)
Mammalian Capabilities (PDF)
Microbial Capabilities (PDF)
Cell Therapy Capabilities (PDF)
Viral Vector Capabilities (PDF)
Plasmid DNA Capabilities (PDF)
Messenger RNA Capabilities (PDF)

Join Us

Career Opportunities

What Drives Us

Life at a CDMO
Diversity, Equity and Inclusion

Meet Our Teams

Seattle
Copenhagen
Heidelberg
Milan
Chiba
Yokohama

Press Releases

Find the latest news on AGC Biologics partnerships, product approvals, site expansions, leadership updates, new programs, and more.

Cell Line Development

AGC Biologics and Novelty Nobility leaders meet to discuss GMP manufacturing of bispecific drug candidate, NN4101 in Tokyo, Japan on April 13, 2026.

2 min read

Novelty Nobility Taps AGC Biologics to Further Develop Bispecific Drug Candidate

May 3, 2026 at 4:45 PM

Mammalian & mAbs Press Release Cell Line Development

Read press release

3 min read

AGC Biologics Partners with ATUM to Accelerate Timelines for Cell Line Development

December 2, 2025 at 6:00 AM

Mammalian & mAbs Press Release Business Updates Cell Line Development

Read press release

AGC Biologics, winner of 2022 Global Excellence Award.

1 min read

AGC Biologics Honored for Innovations in Cell Line Development

October 13, 2022 at 7:46 AM

Mammalian & mAbs Press Release Business Updates Cell Line Development

Read press release

Our Mission

To work side by side with our customers in order to improve patients’ lives by bringing new biopharmaceuticals to market.

Links

About Us
Our Services
Locations
Careers
Contact Us
Media Kit

News

Featured Blog Image

AGC Biologics Joins Orphan Therapeutics Accelerator’s Clinical Development Network as a Manufacturing Partner to Advance Cell and Gene Therapies for Ultra-Rare Diseases

Collaboration brings AGC Biologics’ advanced therapy expertise and global footprint to OTXL’s...

Events

Featured Blog Image

BIO International Convention, June 22-25, 2026

Find us at Booth 4707

Date: June 22-25, 2026

Location: San Diego Convention Center in San Diego, CA

Legal & Compliance

© 2026 AGC Biologics. All Rights Reserved.

AGC Inc. Group